2012 Midyear Clinical Meeting
Click here to go to the previous page
The Tortoise and the Hare of Chronic Kidney Disease: Slowing Disease Progression
Track:
Education Sessions (CE)
Program Code: 201-L01
Date: Wednesday, December 5, 2012
Time: 2:00 PM to 3:30 PM EST
Location:
Mandalay Bay L, Level 2, South Convention Center
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Chanel Agness,
PharmD, BCPS, Assistant Professor,
University of Maryland School of Pharmacy
|
Dr. Agness is an Assistant Professor with the University of Maryland, School of Pharmacy. She is a board certified pharmacotherapy specialist (BCPS), certified geriatric pharmacist (CGP) and has a certficate in Ethnogeriatrics. Her areas of specialization in teaching, research and clinical practice are in geriatric pharmacotherapy and chronic kidney disease (CKD). Dr. Agness established the renal pharmacotherapy clinic as part of a multidisciplinary renal service at the Baltimore Veterans Affairs in 2005. The primary goals of the clinic are to delay progression to End-Stage Renal Disease (ESRD) in veterans with Stage 3-5 CKD through the management of complications and appropriate medication use. She has publised and presented on topics related to management of CKD complications, and medication therapy management in diverse older adults.
|
Thomas Dowling,
PharmD, PhD, Associate Professor and Vice Chair,
University of Maryland
|
Dr. Thomas Dowling is Associate Professor and Vice Chair in the Department of Pharmacy Practice and Science at the University of Maryland. He received his PharmD degree from Ferris State University, completed a residency in pharmacy practice at the University of Maryland Medical Center, and obtained a PhD in Clinical Pharmaceutical Sciences from the University of Pittsburgh. Over the past 15 years he has conducted clinical and translational research in nephrology and pharmacokinetics funded by the NIH, FDA, AFPE, ACCP, NKF and the pharmaceutical industry. He has authored over 40 manuscripts in journals such as Pharmacotherapy, Clinical Pharmacology and Therapeutics, and Circulation, along with book chapters in John Murphy's Clinical Pharmacokinetics, and DiPiro's Pharmacotherapy.
|
Mary Onysko,
PharmD, BCPS, Assistant Clinical Professor of Pharmacy Practice,
University of Wyoming
|
Mary Onysko is a Clinical Assistant Professor of Pharmacy Practice at the University of Wyoming School of Pharmacy and an Assistant Clinical Professor with the Swedish Family Medicine Residency affiliated with the University of Colorado School of Medicine in Denver. She received her doctor of pharmacy degree from Oregon State University in 2006 and completed a primary care specialty residency with Providence Physician Division in Portland, Oregon.
Dr. Onyskos primary responsibilities include experiential and didactic teaching of pharmacy and medical students as well as family practice residents. She teaches in many team-based didactic courses at the University of Wyoming. At her practice site, Dr. Onysko provides ambulatory pharmaceutical care that focuses on patients with diabetes or multiple pharmacotherapy-related problems. She is part of an integrated care team that brings the patient, patients family or caregiver, physician, psychologist, social worker, and pharmacist together to manage complicated health and social problems.
|
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Thomas Dowling,
PharmD, PhD, Associate Professor and Vice Chair,
University of Maryland
|
Dr. Thomas Dowling is Associate Professor and Vice Chair in the Department of Pharmacy Practice and Science at the University of Maryland. He received his PharmD degree from Ferris State University, completed a residency in pharmacy practice at the University of Maryland Medical Center, and obtained a PhD in Clinical Pharmaceutical Sciences from the University of Pittsburgh. Over the past 15 years he has conducted clinical and translational research in nephrology and pharmacokinetics funded by the NIH, FDA, AFPE, ACCP, NKF and the pharmaceutical industry. He has authored over 40 manuscripts in journals such as Pharmacotherapy, Clinical Pharmacology and Therapeutics, and Circulation, along with book chapters in John Murphy's Clinical Pharmacokinetics, and DiPiro's Pharmacotherapy.
|
Description
Update on Estimating GFR and Renal Biomarkers, Thomas Dowling, PharmD, PhD
Hypertensive Nephropathy and Ethnicity, Chanel Agness, PharmD, BCPS
Approaches to Slowing Diabetic Nephropathy, Mary Onysko, PharmD, BCPS
- Recommend strategies for slowing the progression of renal disease in patients with diabetic nephropathy in light of current controversies in the literature.
- Recommend strategies for slowing the progression of renal disease in patients with hypertensive nephropathy.
- Using a set of criteria, evaluate a patient's comprehensive kidney function.
